HomeCompareDSKYF vs PEP

DSKYF vs PEP: Dividend Comparison 2026

DSKYF yields 2.50% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DSKYF wins by $175.45M in total portfolio value
10 years
DSKYF
DSKYF
● Live price
2.50%
Share price
$18.42
Annual div
$0.46
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$175.59M
Annual income
$163,081,726.45
Full DSKYF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — DSKYF vs PEP

📍 DSKYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDSKYFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DSKYF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DSKYF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DSKYF
Annual income on $10K today (after 15% tax)
$212.91/yr
After 10yr DRIP, annual income (after tax)
$138,619,467.48/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, DSKYF beats the other by $138,566,873.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DSKYF + PEP for your $10,000?

DSKYF: 50%PEP: 50%
100% PEP50/50100% DSKYF
Portfolio after 10yr
$87.87M
Annual income
$81,571,801.06/yr
Blended yield
92.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

DSKYF
No analyst data
Altman Z
3.4
Piotroski
6/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DSKYF buys
0
PEP buys
0
No recent congressional trades found for DSKYF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDSKYFPEP
Forward yield2.50%3.63%
Annual dividend / share$0.46$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.4%
Portfolio after 10y$175.59M$141.9K
Annual income after 10y$163,081,726.45$61,875.67
Total dividends collected$174.63M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DSKYF vs PEP ($10,000, DRIP)

YearDSKYF PortfolioDSKYF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$11,201$500.97$10,849$509.42+$352.00DSKYF
2$13,034$1,048.84$11,969$750.47+$1.1KDSKYF
3$16,228$2,281.26$13,500$1,124.14+$2.7KDSKYF
4$22,672$5,308.83$15,680$1,721.66+$7.0KDSKYF
5$38,123$13,863.99$18,929$2,715.34+$19.2KDSKYF
6$84,366$43,574.29$24,023$4,450.80+$60.3KDSKYF
7$270,513$180,241.39$32,510$7,669.92+$238.0KDSKYF
8$1,369,690$1,080,240.94$47,709$14,093.60+$1.32MDSKYF
9$11,689,092$10,223,523.95$77,415$28,083.48+$11.61MDSKYF
10$175,589,055$163,081,726.45$141,922$61,875.67+$175.45MDSKYF

DSKYF vs PEP: Complete Analysis 2026

DSKYFStock

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.

Full DSKYF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this DSKYF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DSKYF vs SCHDDSKYF vs JEPIDSKYF vs ODSKYF vs KODSKYF vs MAINDSKYF vs MODSKYF vs PMDSKYF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.